Tampere, Finland, May 19, 2021—Combinostics, provider of artificial intelligence (AI) technology to help clinicians make evidence-based decisions for the diagnosis and management of neurological disorders, today announced that Richard Hausmann has been named as Chief Executive Officer, effective June 1, 2021. Hausmann will succeed Lennart Thurfjell, who is one of the founders of Combinostics and current Chief Executive Officer. Thurfjell will transition to the role of Chief Operating Officer.
Combinostics’ cDSI and cMRI Applications, Part of the cNeuro Platform, Receive EC-certification Under the EU’s Medical Device Regulation (MDR)
cNeuro® cDSI™ and cNeuro cMRI™ achieve EC-certification under MDR, ensuring continued delivery of services to European customers.